Non-Requirement to Blood Transfusion in a Patent With Myelodysplastc Syndrome Following the Oral Administraton of β-D-Mannuronic Acid: A Case Report

Non-Requirement to Blood Transfusion in a Patent With Myelodysplastc Syndrome Following the Oral Administraton of β-D-Mannuronic Acid: A Case Report

Myelodysplastic Syndromes (MDSs) is a heterogeneous group of hematologic neoplasms that causes cytopenia and dysplasia in one or more major bone marrow cell lines. The patients with this syndrome develop clinical complications associated with progressive bone marrow destruction leading to an increa...

Full description

Bibliographic Details
Main Authors: Afshin Ghaderi, Sayyed Reza Safaee Nodehi, Tahereh Bakhtiari, Abbas Mirshafiey
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2019-08-01
Series:Case Reports in Clinical Practice
Subjects:
D-mannuronic acid (M2000);
Myelodysplastc syndrome (MDS);
Transfusion;
Hematology;
Oncology
Online Access:https://crcp.tums.ac.ir/index.php/crcp/article/view/259

Internet

https://crcp.tums.ac.ir/index.php/crcp/article/view/259

Similar Items